TANDEM DIABETES CARE INC (TNDM)
TANDEM DIABETES CARE INC (TNDM) from its SEC filings: 2025 revenue $1.0 billion (+8% vs the year before), net margin -20%, free cash flow -$29.7 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $1.0 billion |
| Revenue growth | +8% |
| Net income | -$204.7 million |
| Net margin | -20.2% |
| Free cash flow | -$29.7 million |
| Diluted EPS | $-3.04 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +6% |
| Cash | $62.8 million |
| Long-term debt | $602.6 million |
| Share count, 1 year | +3% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.